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Purpose of the Study
The objective of this study is to identify low frequency
mutations in HIV-1C that cannot be detected by standard
genotyping. We analysed samples from the Tshepo cohort
in Botswana. Tshepo is an open-label, unblinded, ran-
domised 3 × 2 × 2 factorial design study comparing 1) the
rate of development and specific types of drug resistance
mutational patterns among HIV-1C-infected adults
treated with 6 initial HAART regimens; (2) the tolerability
and efficacy of these HAART regimens; (3) evaluation of
the When to Start HAART question as patients are initiated
on HAART in two different baseline CD4+ cell count
strata; and (4) comparing the short- and long-term effec-
tiveness of two operational adherence strategies.
Methods
Methodology involved quantification of the proviral load
and multiple PCR with a single copy as a template fol-
lowed by direct sequencing. Bulk sequencing was also car-
ried out for each patient per time point.
Summary of Results
Of the patients who had been enrolled in the study for at
least one year, had longitudinal samples at every two
month visit and had failed the first-line therapy, failed
therapy, 30% of them showed no drug resistance muta-
tions prior to the point of virological failureby single
genome sequencing. Single genome sequencing revealed
drug resistance mutations for the remaining 70% of the
patients before virological failure was experienced.
Conclusion
Single genome sequencing allows for the detection of low
frequency mutation below the threshold of 30% for bulk
sequencing, allows early detection of these mutations for
some samples and in addition can detect mutations oth-
erwise missed by conventional methods of detection
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